195 related articles for article (PubMed ID: 31563809)
1. Enzyme-encapsulating polymeric nanoparticles: A potential adjunctive therapy in Pseudomonas aeruginosa biofilm-associated infection treatment.
Han C; Goodwine J; Romero N; Steck KS; Sauer K; Doiron A
Colloids Surf B Biointerfaces; 2019 Dec; 184():110512. PubMed ID: 31563809
[TBL] [Abstract][Full Text] [Related]
2. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
[TBL] [Abstract][Full Text] [Related]
3. Utilizing nanoparticles for improving anti-biofilm effects of azithromycin: A head-to-head comparison of modified hyaluronic acid nanogels and coated poly (lactic-co-glycolic acid) nanoparticles.
Kłodzińska SN; Wan F; Jumaa H; Sternberg C; Rades T; Nielsen HM
J Colloid Interface Sci; 2019 Nov; 555():595-606. PubMed ID: 31404843
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.
Goodwine J; Gil J; Doiron A; Valdes J; Solis M; Higa A; Davis S; Sauer K
Sci Rep; 2019 Mar; 9(1):3763. PubMed ID: 30842579
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Red Propolis in Polymer Nanoparticles for the Destruction of Pathogenic Biofilms.
de Mélo Silva IS; do Amorim Costa Gaspar LM; Rocha AMO; da Costa LP; Tada DB; Franceschi E; Padilha FF
AAPS PharmSciTech; 2020 Jan; 21(2):49. PubMed ID: 31900606
[TBL] [Abstract][Full Text] [Related]
6. Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into
Wan F; Bohr SS; Kłodzińska SN; Jumaa H; Huang Z; Nylander T; Thygesen MB; Sørensen KK; Jensen KJ; Sternberg C; Hatzakis N; Mørck Nielsen H
ACS Appl Mater Interfaces; 2020 Jan; 12(1):380-389. PubMed ID: 31804792
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection.
Abdelghany SM; Quinn DJ; Ingram RJ; Gilmore BF; Donnelly RF; Taggart CC; Scott CJ
Int J Nanomedicine; 2012; 7():4053-63. PubMed ID: 22915848
[TBL] [Abstract][Full Text] [Related]
8. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
[TBL] [Abstract][Full Text] [Related]
10. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
Günday Türeli N; Türeli AE; Schneider M
Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
[TBL] [Abstract][Full Text] [Related]
11. In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.
Cho DY; Lim DJ; Mackey C; Weeks CG; Garcia JAP; Skinner D; Zhang S; McCormick J; Woodworth BA
Int Forum Allergy Rhinol; 2019 May; 9(5):486-492. PubMed ID: 30702211
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Activatable Phase-Shift Nanoparticle as a Targeting Antibacterial Agent for Efficient Eradication of
Xin L; Zhang C; Chen J; Jiang Y; Liu Y; Jin P; Wang X; Wang G; Huang P
ACS Appl Mater Interfaces; 2022 Oct; 14(42):47420-47431. PubMed ID: 36222290
[TBL] [Abstract][Full Text] [Related]
13. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
[TBL] [Abstract][Full Text] [Related]
14. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
[TBL] [Abstract][Full Text] [Related]
15. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Shaaban MI; Shaker MA; Mady FM
J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
[TBL] [Abstract][Full Text] [Related]
17. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
18. Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo.
Singh N; Romero M; Travanut A; Monteiro PF; Jordana-Lluch E; Hardie KR; Williams P; Alexander MR; Alexander C
Biomater Sci; 2019 Sep; 7(10):4099-4111. PubMed ID: 31355397
[TBL] [Abstract][Full Text] [Related]
19. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
[TBL] [Abstract][Full Text] [Related]
20. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
